Cite
Association between timely targeted treatment and outcomes in patients with metastatic HER2‐overexpressing gastroesophageal adenocarcinoma.
MLA
Lau, Min, Kelsey S., et al. “Association between Timely Targeted Treatment and Outcomes in Patients with Metastatic HER2‐overexpressing Gastroesophageal Adenocarcinoma.” Cancer (0008543X), vol. 128, no. 9, May 2022, pp. 1853–62. EBSCOhost, https://doi.org/10.1002/cncr.34117.
APA
Lau, M. K. S., Li, Y., Eads, J. R., Mamtani, R., & Getz, K. D. (2022). Association between timely targeted treatment and outcomes in patients with metastatic HER2‐overexpressing gastroesophageal adenocarcinoma. Cancer (0008543X), 128(9), 1853–1862. https://doi.org/10.1002/cncr.34117
Chicago
Lau, Min, Kelsey S., Yimei Li, Jennifer R. Eads, Ronac Mamtani, and Kelly D. Getz. 2022. “Association between Timely Targeted Treatment and Outcomes in Patients with Metastatic HER2‐overexpressing Gastroesophageal Adenocarcinoma.” Cancer (0008543X) 128 (9): 1853–62. doi:10.1002/cncr.34117.